New Trend in Narcotic Drugs Synthetic Cannabinoids
DOI:
https://doi.org/10.17986/blm.2014193775Keywords:
synthetic cannabinoid, bonsai, narcotic drugAbstract
Natural cannabis (Δ9-THC, tetrahydrocannabinol) is obtained from Indian hemp plant (Cannabis sativa) and it acts on cannabinoid receptors expressed as CB1, CB2. The therapeutic effects of cannabis is known from far away times. At the present time, some drugs containing kannabinoid are used for medical purposes. Synthetic cannabinoids’ chemical structure is quite different than natural cannabis. Cannabinoid receptor affinity and activity are greater than the natural cannabis. Substances containing synthetic cannabinoids are generally called “Spice”, “K2” abroad and, “Bonzai” or “Jamaica” in Turkey. Legal sale of herbal mixtures containing synthetic cannabinoids at places called “head shop” and “smart shop” in some countries and having easily access to them from the internet is an attractive feature for users. Moreover the impact stronger than cannabis, affordability, easy accessibility and getting rid of standard material tests contribute to increasing use of synthetic cannabinoids. As there is absence of reference standards of synthetic cannabinoids, it is not easy to identify them. In order to overcome legal barriers, new cannabinomimetic analogs are presented to market constantly. When taking into consideration of the increase of the use of synthetic cannabinoids, it is expected to be one of the most problematic drugs in the near future. Due to the widespread abuse of synthetic cannabinoids, further investigation of these substances is needed for better identification of their pharmacology and toxicology and to make appropriate legal planning and arrangements.
Keywords: Synthetic cannabinoid, bonzai, narcotic drug.
Downloads
References
Aşıcıoğlu F. Yeni Nesil Psiko-Aktif Maddeler. Yeni Nesil Psiko-Aktif Maddeler Sempozyumu Kitabı 2013:3-5 (erişim: http://www.atk.gov.tr/Pdf/psikoakifmaddeler.pdf, erişim tarihi: 05/03/2014)
Yargıç İ. Sentetik kannabinoidler. Yeni Nesil Psiko-Aktif Maddeler Sempozyumu Kitabı 2013:9-11 (erişim: http://www.atk.gov.tr/Pdf/psikoakifmaddeler.pdf, erişim tarihi: 05/03/2014)
Drummer O, Odell M. The Forensic Pharmacology Of Drugs Of Abuse. London: Arnold, 2001.
Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 2001;178(2):101-6. DOI: https://doi.org/10.1192/bjp.178.2.101
Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006;58(3):389-462. DOI: https://doi.org/10.1124/pr.58.3.2
Ottani A, Giuliani D. HU 210: a potent tool for investigations of the cannabinoid system. CNS Drug Rev 2001;7(2):131-45. DOI: https://doi.org/10.1111/j.1527-3458.2001.tb00192.x
Huffman JW, Dai D, Martin BR, Compton DR. Design, synthesis and pharmacology of cannabimimetic indoles. Bioorg Med Chem Lett 1994;4:563-6. DOI: https://doi.org/10.1016/S0960-894X(01)80155-4
Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med 2012;60:435-8. DOI: https://doi.org/10.1016/j.annemergmed.2012.03.007
Hermanns-Clausen M, Kneisel S, Szabo B, Auwärter V. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction. 2013;108(3):534-44. DOI: https://doi.org/10.1111/j.1360-0443.2012.04078.x
Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Rev 2002;54(2):161-202. DOI: https://doi.org/10.1124/pr.54.2.161
Recommended Methods for The Identification and Analysis of Synthetic Cannabinoid Receptor Agonists in Seized Materials, UNODC. (Erişim: http://www.unodc.org/documents/scientific/STNAR48_Synthetic_Cannabinoids_ENG.pdf, erişim tarihi: 12/03/2014)
Ogata J, Uchiyama N, Kikura-Hanajiri R, Goda Y. DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs. Forensic Sci Int 2013;227(1-3):33-41. DOI: https://doi.org/10.1016/j.forsciint.2012.09.006
Eker H. Sentetik Esrar İmalat Ticaret ve Arz Problemi. Yeni Nesil Psiko-Aktif Maddeler Sempozyumu Kitabı 2013:5-6 (erişim: http://www.atk.gov.tr/Pdf/psikoakifmaddeler.pdf, erişim tarihi: 05/03/2014)
Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of Spice products (synthetic cannabinoids). Drug Alcohol Depend 2012;120:238-41. DOI: https://doi.org/10.1016/j.drugalcdep.2011.07.011
Akgül A, Aşıcıoğlu F. Uyuşturucu Maddelerde Yeni Trendler ve Erken Uyarı Sistemi. İçinde: Demir OÖ, Sever M, editörler. Örgütlü Suçlar ve Yeni Trendler. Ankara: Polis Akademisi Yayınları; 2011.p. 29-56.
2013 Türkiye Uyuşturucu Raporu. (Erişim: http://www.kom.gov.tr/Tr/Dosyalar/2013_TURKIYE_UYUSTURUCU_RAPORU.pdf. erişim tarihi: 07/03/2014)
Gurdal F, Asirdizer M, Aker RG, Korkut S, Gocer Y, Kucukibrahimoglu EE, Ince CH. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey. J Forensic Leg Med 2013;20(6):667-72. DOI: https://doi.org/10.1016/j.jflm.2013.03.041
Elsohly MA, Gul W, Wanas AS, Radwan MM. Synthetic cannabinoids: analysis and metabolites. Life Sci 2014;97(1):78-90. DOI: https://doi.org/10.1016/j.lfs.2013.12.212
Pertwee RG. Pharmacology of cannabinoid receptor ligands. Curr Med Chem 1999;6:635-64. DOI: https://doi.org/10.2174/0929867306666220401124036
Evren C, Bozkurt M. Sentetik kannabinoidler: son yılların krizi. Düşünen Adam: Psikiyatri ve Nörolojik Bilimler Dergisi 2013;26:1-11.
Moosmann B, Kneisel S, Girreser U, Brecht V, Westphal F, Auwärter V. Withdrawal phenomena and dependence syndrome after the consumption of “spice gold”. Dtsch Arztebl Int 2009;106:464-7.
Seely KA, Brents LK, Radominska-Pandya A, Endres GW, Keyes GS, Moran JH, Prather PL. A major glucuronidatedmetabolite of JWH-018 is a neutral antagonist at CB1 receptors. Chem Res Toxicol 2012;25:825-7. DOI: https://doi.org/10.1021/tx3000472
Perspectives on drugs, synthetic cannabinoids in Europe, EMCDDA. (Erişim:http://www.emcdda.europa.eu/attachements.cfm/att_212361_EN_EMCDDA_POD_2013_Synthetic%20cannabinoids.pdf. erişim tarihi 12/03/2014)
Hurst D, Loeffler G, McLay R. Psychosis associated with synthetic cannabinoid agonists: a case series. Am J Psychiatry 2011;168(10):1119. DOI: https://doi.org/10.1176/appi.ajp.2011.11010176
Freeman MJ, Rose DZ, Myers MA, Gooch CL, Bozeman AC, Burgin WS. Ischemic stroke after use of the synthetic marijuana "spice". Neurology 2013;81(24):2090-3. DOI: https://doi.org/10.1212/01.wnl.0000437297.05570.a2
Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones bath salts), Kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 2012;8:15-32. DOI: https://doi.org/10.1007/s13181-011-0202-2
Bazı Maddelerin 2313 Sayılı Uyuşturucu Maddelerin Murakabesi Hakkında Kanun Hükümlerine Tabi Tutulması Hakkında 2011/1310 Sayılı Karar. (Erişim: http://www.resmi-gazete.org/rega/2011-1310-bazi-maddelerin-2313-sayili-uyusturucu-maddelerin-murakabesi-hakkinda-kanun-hukumlerine-tabi-tutulmasi-hakkinda-karar-460.htm. erişim tarihi: 10/03/2014)
Başak AS. Psikoaktif Maddelerin Analiz ve Bilirkişilik Boyutu. Yeni Nesil Psiko-Aktif Maddeler Sempozyumu Kitabı 2013:5-6 (erişim: http://www.atk.gov.tr/Pdf/psikoakifmaddeler.pdf, erişim tarihi: 05/03/2014)
Fattore L, Fratta W. Beyond THC: The new generation of cannabinoid designer drugs. Front Behav Neurosci 2011;5:60-6. DOI: https://doi.org/10.3389/fnbeh.2011.00060
AAPCC Issues Statement on the Synthetic Drug Abuse Prevention Act. American Association of Poison Control Centre, 2012. (Erişim: http://www.aapcc.org/press/2/. erişim tarihi:11/03/2014)
Downloads
Published
Issue
Section
License
The Journal and content of this website is licensed under the terms of the Creative Commons Attribution (CC BY) License. The Creative Commons Attribution License (CC BY) allows users to copy, distribute and transmit an article, adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed.